FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

39293111000001109: Irinotecan 300mg/200ml infusion bags (Sun Pharmaceutical Industries Europe B.V.) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Jan 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
562121000001113 Irinotecan 300mg/200ml infusion bags (Sun Pharmaceutical Industries Europe B.V.) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
562141000001115 Irinotecan 300mg/200ml infusion bags (Sun Pharmaceutical Industries Europe B.V.) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Irinotecan 300mg/200ml infusion bags (Sun Pharmaceutical Industries Europe B.V.) Has dispensed dose form Infusion true Inferred relationship Existential restriction modifier
Irinotecan 300mg/200ml infusion bags (Sun Pharmaceutical Industries Europe B.V.) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Irinotecan 300mg/200ml infusion bags (Sun Pharmaceutical Industries Europe B.V.) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Irinotecan 300mg/200ml infusion bags (Sun Pharmaceutical Industries Europe B.V.) Is a Irinotecan 300mg/200ml infusion bags true Inferred relationship Existential restriction modifier
Irinotecan 300mg/200ml infusion bags (Sun Pharmaceutical Industries Europe B.V.) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Irinotecan 300mg/200ml infusion bags (Sun Pharmaceutical Industries Europe B.V.) Has specific active ingredient Irinotecan hydrochloride trihydrate true Inferred relationship Existential restriction modifier
Irinotecan 300mg/200ml infusion bags (Sun Pharmaceutical Industries Europe B.V.) Has dispensed dose form Conventional release solution for infusion false Inferred relationship Existential restriction modifier
Irinotecan 300mg/200ml infusion bags (Sun Pharmaceutical Industries Europe B.V.) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Irinotecan 300mg/200ml infusion bags (Sun Pharmaceutical Industries Europe B.V.) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Irinotecan 300mg/200ml infusion bags (Sun Pharmaceutical Industries Europe B.V.) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Irinotecan 300mg/200ml infusion bags (Sun Pharmaceutical Industries Europe B.V.) 1 bag Has AMP True Irinotecan 300mg/200ml infusion bags (Sun Pharmaceutical Industries Europe B.V.) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start